調査レポート | • レポートコード：GIR-2104Z10664 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、PDE阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。PDE阻害剤の種類別市場規模（PDE5、PDE4、バイアグラ、シアリス、レビトラ、その他）、用途別市場規模（泌尿生殖器、心血管疾患、皮膚疾患、呼吸器疾患、統合失調症、アルツハイマー病、ハンチントン病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・PDE阻害剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Hanmi Science Holding、Boehringer Ingelheim、Takeda Pharmaceuticals、AstraZeneca、Bayer、Celgene、Eli Lilly、Pfizer、BioCrea、Dart NeuroScience、Carinopharm、CTC Bio、FORUM Pharmaceuticals、Intra-Cellular Therapies、Omeros Corporation、Medimetriks Pharmaceuticals、NuSirt Biopharma、Palobiopharma、Roivant Sciences、Sagene Pharmaceuticals、Tetra Discovery Partners、Tritech Biopharm、Otsuka、Chiesi Farmaceutici、Verona Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：PDE5、PDE4、バイアグラ、シアリス、レビトラ、その他 ・用途別分析2016年-2026年：泌尿生殖器、心血管疾患、皮膚疾患、呼吸器疾患、統合失調症、アルツハイマー病、ハンチントン病、その他 ・PDE阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・PDE阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・PDE阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・PDE阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・PDE阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The PDE Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global PDE Inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global PDE Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
PDE Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PDE5
PDE4
Viagra
Cialis
Levitra
Others
Market segment by Application can be divided into
Genitourinary
Cardiovascular Diseases
Dermatological Disorders
Respiratory Diseases
Schizophrenia
Alzheimer’S Disease
Huntington’S Disease
Others
The key market players for global PDE Inhibitors market are listed below:
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
AstraZeneca
Bayer
Celgene
Eli Lilly
Pfizer
BioCrea
Dart NeuroScience
Carinopharm
CTC Bio
FORUM Pharmaceuticals
Intra-Cellular Therapies
Omeros Corporation
Medimetriks Pharmaceuticals
NuSirt Biopharma
Palobiopharma
Roivant Sciences
Sagene Pharmaceuticals
Tetra Discovery Partners
Tritech Biopharm
Otsuka
Chiesi Farmaceutici
Verona Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 PDE Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PDE Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 PDE5
1.2.3 PDE4
1.2.4 Viagra
1.2.5 Cialis
1.2.6 Levitra
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PDE Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Genitourinary
1.3.3 Cardiovascular Diseases
1.3.4 Dermatological Disorders
1.3.5 Respiratory Diseases
1.3.6 Schizophrenia
1.3.7 Alzheimer’S Disease
1.3.8 Huntington’S Disease
1.3.9 Others
1.4 Global PDE Inhibitors Market Size & Forecast
1.4.1 Global PDE Inhibitors Sales in Value (2016-2026))
1.4.2 Global PDE Inhibitors Sales in Volume (2016-2026)
1.4.3 Global PDE Inhibitors Price by Type (2016-2026) & (USD/Unit)
1.5 Global PDE Inhibitors Production Capacity Analysis
1.5.1 Global PDE Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global PDE Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PDE Inhibitors Market Drivers
1.6.2 PDE Inhibitors Market Restraints
1.6.3 PDE Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Hanmi Science Holding
2.1.1 Hanmi Science Holding Details
2.1.2 Hanmi Science Holding Major Business
2.1.3 Hanmi Science Holding PDE Inhibitors Product and Services
2.1.4 Hanmi Science Holding PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim PDE Inhibitors Product and Services
2.2.4 Boehringer Ingelheim PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Takeda Pharmaceuticals
2.3.1 Takeda Pharmaceuticals Details
2.3.2 Takeda Pharmaceuticals Major Business
2.3.3 Takeda Pharmaceuticals PDE Inhibitors Product and Services
2.3.4 Takeda Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca PDE Inhibitors Product and Services
2.4.4 AstraZeneca PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer PDE Inhibitors Product and Services
2.5.4 Bayer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business
2.6.3 Celgene PDE Inhibitors Product and Services
2.6.4 Celgene PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly PDE Inhibitors Product and Services
2.7.4 Eli Lilly PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer PDE Inhibitors Product and Services
2.8.4 Pfizer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 BioCrea
2.9.1 BioCrea Details
2.9.2 BioCrea Major Business
2.9.3 BioCrea PDE Inhibitors Product and Services
2.9.4 BioCrea PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Dart NeuroScience
2.10.1 Dart NeuroScience Details
2.10.2 Dart NeuroScience Major Business
2.10.3 Dart NeuroScience PDE Inhibitors Product and Services
2.10.4 Dart NeuroScience PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Carinopharm
2.11.1 Carinopharm Details
2.11.2 Carinopharm Major Business
2.11.3 Carinopharm PDE Inhibitors Product and Services
2.11.4 Carinopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 CTC Bio
2.12.1 CTC Bio Details
2.12.2 CTC Bio Major Business
2.12.3 CTC Bio PDE Inhibitors Product and Services
2.12.4 CTC Bio PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 FORUM Pharmaceuticals
2.13.1 FORUM Pharmaceuticals Details
2.13.2 FORUM Pharmaceuticals Major Business
2.13.3 FORUM Pharmaceuticals PDE Inhibitors Product and Services
2.13.4 FORUM Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Intra-Cellular Therapies
2.14.1 Intra-Cellular Therapies Details
2.14.2 Intra-Cellular Therapies Major Business
2.14.3 Intra-Cellular Therapies PDE Inhibitors Product and Services
2.14.4 Intra-Cellular Therapies PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Omeros Corporation
2.15.1 Omeros Corporation Details
2.15.2 Omeros Corporation Major Business
2.15.3 Omeros Corporation PDE Inhibitors Product and Services
2.15.4 Omeros Corporation PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Medimetriks Pharmaceuticals
2.16.1 Medimetriks Pharmaceuticals Details
2.16.2 Medimetriks Pharmaceuticals Major Business
2.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
2.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 NuSirt Biopharma
2.17.1 NuSirt Biopharma Details
2.17.2 NuSirt Biopharma Major Business
2.17.3 NuSirt Biopharma PDE Inhibitors Product and Services
2.17.4 NuSirt Biopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Palobiopharma
2.18.1 Palobiopharma Details
2.18.2 Palobiopharma Major Business
2.18.3 Palobiopharma PDE Inhibitors Product and Services
2.18.4 Palobiopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Roivant Sciences
2.19.1 Roivant Sciences Details
2.19.2 Roivant Sciences Major Business
2.19.3 Roivant Sciences PDE Inhibitors Product and Services
2.19.4 Roivant Sciences PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Sagene Pharmaceuticals
2.20.1 Sagene Pharmaceuticals Details
2.20.2 Sagene Pharmaceuticals Major Business
2.20.3 Sagene Pharmaceuticals PDE Inhibitors Product and Services
2.20.4 Sagene Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Tetra Discovery Partners
2.21.1 Tetra Discovery Partners Details
2.21.2 Tetra Discovery Partners Major Business
2.21.3 Tetra Discovery Partners PDE Inhibitors Product and Services
2.21.4 Tetra Discovery Partners PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Tritech Biopharm
2.22.1 Tritech Biopharm Details
2.22.2 Tritech Biopharm Major Business
2.22.3 Tritech Biopharm PDE Inhibitors Product and Services
2.22.4 Tritech Biopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Otsuka
2.23.1 Otsuka Details
2.23.2 Otsuka Major Business
2.23.3 Otsuka PDE Inhibitors Product and Services
2.23.4 Otsuka PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.24 Chiesi Farmaceutici
2.24.1 Chiesi Farmaceutici Details
2.24.2 Chiesi Farmaceutici Major Business
2.24.3 Chiesi Farmaceutici PDE Inhibitors Product and Services
2.24.4 Chiesi Farmaceutici PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.25 Verona Pharma
2.25.1 Verona Pharma Details
2.25.2 Verona Pharma Major Business
2.25.3 Verona Pharma PDE Inhibitors Product and Services
2.25.4 Verona Pharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 PDE Inhibitors Sales by Manufacturer
3.1 Global PDE Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global PDE Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in PDE Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 PDE Inhibitors Manufacturer Market Share
3.4.2 Top 6 PDE Inhibitors Manufacturer Market Share
3.5 Global PDE Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and PDE Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PDE Inhibitors Market Size by Region
4.1.1 Global PDE Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global PDE Inhibitors Revenue by Region (2016-2026)
4.2 North America PDE Inhibitors Revenue (2016-2026)
4.3 Europe PDE Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific PDE Inhibitors Revenue (2016-2026)
4.5 South America PDE Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa PDE Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global PDE Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global PDE Inhibitors Revenue by Type (2016-2026)
5.3 Global PDE Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global PDE Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global PDE Inhibitors Revenue by Application (2016-2026)
6.3 Global PDE Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America PDE Inhibitors Sales by Type (2016-2026)
7.2 North America PDE Inhibitors Sales by Application (2016-2026)
7.3 North America PDE Inhibitors Market Size by Country
7.3.1 North America PDE Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America PDE Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe PDE Inhibitors Sales by Type (2016-2026)
8.2 Europe PDE Inhibitors Sales by Application (2016-2026)
8.3 Europe PDE Inhibitors Market Size by Country
8.3.1 Europe PDE Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe PDE Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific PDE Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific PDE Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific PDE Inhibitors Market Size by Region
9.3.1 Asia-Pacific PDE Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific PDE Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America PDE Inhibitors Sales by Type (2016-2026)
10.2 South America PDE Inhibitors Sales by Application (2016-2026)
10.3 South America PDE Inhibitors Market Size by Country
10.3.1 South America PDE Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America PDE Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PDE Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa PDE Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa PDE Inhibitors Market Size by Country
11.3.1 Middle East & Africa PDE Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa PDE Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 PDE Inhibitors Typical Distributors
12.3 PDE Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global PDE Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global PDE Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. Hanmi Science Holding Basic Information, Manufacturing Base and Competitors
Table 4. Hanmi Science Holding Major Business
Table 5. Hanmi Science Holding PDE Inhibitors Product and Services
Table 6. Hanmi Science Holding PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim PDE Inhibitors Product and Services
Table 10. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceuticals Major Business
Table 13. Takeda Pharmaceuticals PDE Inhibitors Product and Services
Table 14. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca PDE Inhibitors Product and Services
Table 18. AstraZeneca PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer PDE Inhibitors Product and Services
Table 22. Bayer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celgene Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Major Business
Table 25. Celgene PDE Inhibitors Product and Services
Table 26. Celgene PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly PDE Inhibitors Product and Services
Table 30. Eli Lilly PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer PDE Inhibitors Product and Services
Table 34. Pfizer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. BioCrea Basic Information, Manufacturing Base and Competitors
Table 36. BioCrea Major Business
Table 37. BioCrea PDE Inhibitors Product and Services
Table 38. BioCrea PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Dart NeuroScience Basic Information, Manufacturing Base and Competitors
Table 40. Dart NeuroScience Major Business
Table 41. Dart NeuroScience PDE Inhibitors Product and Services
Table 42. Dart NeuroScience PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Carinopharm Basic Information, Manufacturing Base and Competitors
Table 44. Carinopharm Major Business
Table 45. Carinopharm PDE Inhibitors Product and Services
Table 46. Carinopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. CTC Bio Basic Information, Manufacturing Base and Competitors
Table 48. CTC Bio Major Business
Table 49. CTC Bio PDE Inhibitors Product and Services
Table 50. CTC Bio PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. FORUM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. FORUM Pharmaceuticals Major Business
Table 53. FORUM Pharmaceuticals PDE Inhibitors Product and Services
Table 54. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Intra-Cellular Therapies Basic Information, Manufacturing Base and Competitors
Table 56. Intra-Cellular Therapies Major Business
Table 57. Intra-Cellular Therapies PDE Inhibitors Product and Services
Table 58. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Omeros Corporation Major Business
Table 61. Omeros Corporation PDE Inhibitors Product and Services
Table 62. Omeros Corporation PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Medimetriks Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Medimetriks Pharmaceuticals Major Business
Table 65. Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
Table 66. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. NuSirt Biopharma Basic Information, Manufacturing Base and Competitors
Table 68. NuSirt Biopharma Major Business
Table 69. NuSirt Biopharma PDE Inhibitors Product and Services
Table 70. NuSirt Biopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Palobiopharma Basic Information, Manufacturing Base and Competitors
Table 72. Palobiopharma Major Business
Table 73. Palobiopharma PDE Inhibitors Product and Services
Table 74. Palobiopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Roivant Sciences Basic Information, Manufacturing Base and Competitors
Table 76. Roivant Sciences Major Business
Table 77. Roivant Sciences PDE Inhibitors Product and Services
Table 78. Roivant Sciences PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Sagene Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagene Pharmaceuticals Major Business
Table 81. Sagene Pharmaceuticals PDE Inhibitors Product and Services
Table 82. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Tetra Discovery Partners Basic Information, Manufacturing Base and Competitors
Table 84. Tetra Discovery Partners Major Business
Table 85. Tetra Discovery Partners PDE Inhibitors Product and Services
Table 86. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Tritech Biopharm Basic Information, Manufacturing Base and Competitors
Table 88. Tritech Biopharm Major Business
Table 89. Tritech Biopharm PDE Inhibitors Product and Services
Table 90. Tritech Biopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Otsuka Basic Information, Manufacturing Base and Competitors
Table 92. Otsuka Major Business
Table 93. Otsuka PDE Inhibitors Product and Services
Table 94. Otsuka PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 96. Chiesi Farmaceutici Major Business
Table 97. Chiesi Farmaceutici PDE Inhibitors Product and Services
Table 98. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Verona Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Verona Pharma Major Business
Table 101. Verona Pharma PDE Inhibitors Product and Services
Table 102. Verona Pharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global PDE Inhibitors Sales by Manufacturer (2019-2021e) & (K Units)
Table 104. Global PDE Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in PDE Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global PDE Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 107. Head Office and PDE Inhibitors Production Site of Key Manufacturer
Table 108. Global PDE Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 109. Global PDE Inhibitors Sales by Region (2021-2026) & (K Units)
Table 110. Global PDE Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 111. Global PDE Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 112. Global PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 113. Global PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 114. Global PDE Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 115. Global PDE Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 116. Global PDE Inhibitors Price by Type (2016-2021e) & (USD/Unit)
Table 117. Global PDE Inhibitors Price by Type (2021-2026) & (USD/Unit)
Table 118. Global PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 119. Global PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 120. Global PDE Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 121. Global PDE Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 122. Global PDE Inhibitors Price by Application (2016-2021e) & (USD/Unit)
Table 123. Global PDE Inhibitors Price by Application (2021-2026) & (USD/Unit)
Table 124. North America PDE Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 125. North America PDE Inhibitors Sales by Country (2021-2026) & (K Units)
Table 126. North America PDE Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 127. North America PDE Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 128. North America PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 129. North America PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 130. North America PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 131. North America PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 132. Europe PDE Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 133. Europe PDE Inhibitors Sales by Country (2021-2026) & (K Units)
Table 134. Europe PDE Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 135. Europe PDE Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 136. Europe PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 137. Europe PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 138. Europe PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 139. Europe PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 140. Asia-Pacific PDE Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 141. Asia-Pacific PDE Inhibitors Sales by Region (2021-2026) & (K Units)
Table 142. Asia-Pacific PDE Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 143. Asia-Pacific PDE Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 145. Asia-Pacific PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 146. Asia-Pacific PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 147. Asia-Pacific PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 148. South America PDE Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 149. South America PDE Inhibitors Sales by Country (2021-2026) & (K Units)
Table 150. South America PDE Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 151. South America PDE Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 152. South America PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 153. South America PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 154. South America PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 155. South America PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 156. Middle East & Africa PDE Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 157. Middle East & Africa PDE Inhibitors Sales by Country (2021-2026) & (K Units)
Table 158. Middle East & Africa PDE Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 159. Middle East & Africa PDE Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa PDE Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 161. Middle East & Africa PDE Inhibitors Sales by Type (2021-2026) & (K Units)
Table 162. Middle East & Africa PDE Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 163. Middle East & Africa PDE Inhibitors Sales by Application (2021-2026) & (K Units)
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. PDE Inhibitors Typical Distributors
Table 167. PDE Inhibitors Typical Customers
List of Figures
Figure 1. PDE Inhibitors Picture
Figure 2. Global PDE Inhibitors Sales Market Share by Type in 2020
Figure 3. PDE5
Figure 4. PDE4
Figure 5. Viagra
Figure 6. Cialis
Figure 7. Levitra
Figure 8. Others
Figure 9. Global PDE Inhibitors Sales Market Share by Application in 2020
Figure 10. Genitourinary
Figure 11. Cardiovascular Diseases
Figure 12. Dermatological Disorders
Figure 13. Respiratory Diseases
Figure 14. Schizophrenia
Figure 15. Alzheimer’S Disease
Figure 16. Huntington’S Disease
Figure 17. Others
Figure 18. Global PDE Inhibitors Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 19. Global PDE Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 20. United States PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Canada PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Mexico PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Germany PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. France PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. United Kingdom PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Russia PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Italy PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. China PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Japan PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Korea PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. India PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Southeast Asia PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Australia PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Brazil PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Egypt PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Saudi Arabia PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. South Africa PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Turkey PDE Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Global PDE Inhibitors Sales (2016-2026) & (K Units)
Figure 40. Global PDE Inhibitors Production Capacity (2016-2026) & (K Units)
Figure 41. Global PDE Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 42. PDE Inhibitors Market Drivers
Figure 43. PDE Inhibitors Market Restraints
Figure 44. PDE Inhibitors Market Trends
Figure 45. Global PDE Inhibitors Sales Market Share by Manufacturer in 2020
Figure 46. Global PDE Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 47. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 48. Top 3 PDE Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 49. Top 6 PDE Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 50. Global PDE Inhibitors Sales Market Share by Region (2016-2026)
Figure 51. Global PDE Inhibitors Revenue Market Share by Region (2016-2026)
Figure 52. North America PDE Inhibitors Revenue (2016-2026) & (USD Million)
Figure 53. Europe PDE Inhibitors Revenue (2016-2026) & (USD Million)
Figure 54. Asia-Pacific PDE Inhibitors Revenue (2016-2026) & (USD Million)
Figure 55. South America PDE Inhibitors Revenue (2016-2026) & (USD Million)
Figure 56. Middle East & Africa PDE Inhibitors Revenue (2016-2026) & (USD Million)
Figure 57. Global PDE Inhibitors Sales Market Share by Type (2016-2026)
Figure 58. Global PDE Inhibitors Revenue Market Share by Type (2016-2026)
Figure 59. Global PDE Inhibitors Price by Type (2016-2026) & (USD/Unit)
Figure 60. Global PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 61. Global PDE Inhibitors Revenue Market Share by Application (2016-2026)
Figure 62. Global PDE Inhibitors Price by Application (2016-2026) & (USD/Unit)
Figure 63. North America PDE Inhibitors Sales Market Share by Country (2016-2026)
Figure 64. North America PDE Inhibitors Revenue Market Share by Country (2016-2026)
Figure 65. North America PDE Inhibitors Sales Market Share by Type (2016-2026)
Figure 66. North America PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 67. Europe PDE Inhibitors Sales Market Share by Country (2016-2026)
Figure 68. Europe PDE Inhibitors Revenue Market Share by Country (2016-2026)
Figure 69. Europe PDE Inhibitors Sales Market Share by Type (2016-2026)
Figure 70. Europe PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 71. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific PDE Inhibitors Revenue Market Share by Region (2016-2026)
Figure 73. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2016-2026)
Figure 74. Asia-Pacific PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 75. South America PDE Inhibitors Sales Market Share by Country (2016-2026)
Figure 76. South America PDE Inhibitors Revenue Market Share by Country (2016-2026)
Figure 77. South America PDE Inhibitors Sales Market Share by Type (2016-2026)
Figure 78. South America PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 79. Middle East & Africa PDE Inhibitors Sales Market Share by Country (2016-2026)
Figure 80. Middle East & Africa PDE Inhibitors Revenue Market Share by Country (2016-2026)
Figure 81. Middle East & Africa PDE Inhibitors Sales Market Share by Type (2016-2026)
Figure 82. Middle East & Africa PDE Inhibitors Sales Market Share by Application (2016-2026)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界のTNF阻害剤市場規模・現状・予測（2021年-2027年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…- 世界のシグナル伝達阻害剤市場規模・現状・予測（2021年-2027年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…
- 世界のmTOR阻害剤市場 2021：企業別、地域別、種類・用途別 The mTOR Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…